Expression of sex hormone-binding globulin, oxytocin receptor, caveolin-1 and p21 in leiomyoma

References

• Burroughs K D, Fuchs-Young R, Davis B, Walker C L. Altered hormonal responsiveness of proliferation and apoptosis during myometrial maturation and the development of uterine leiomyomas in the rat. Biol Reprod 2000; 63: 1322–1330
   PubMedGoogle Scholar
• Cramer S F, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol 1990; 94: 435–438
   PubMed Web of Science ®Google Scholar
• Leitao M M, Soslow R A, Nonaka D, Olshen A B, Aghajanian C, Sabbatini P, Dupont J, Hensley M, Sonoda Y, Barakat R R, et al. Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma. Cancer 2004; 6: 1455–1462
   Google Scholar
• Shime H, Kariya M, Orii A, Momma C, Kanamori T, Fukuhara K, Kusakari T, Tsurata Y, Takakura K, Nikaido T, et al. Tranilast inhibits the proliferation of uterine leiomyoma cells in vitro through G1 arrest associated with the induction of p21waf1 and p53. J Clin Endocrinol Metab 2002; 87: 5610–5617
   PubMedGoogle Scholar
• Johannisson R. Zur Genetik und Pathogenese des Uterus myomatosus. Gynakol Endokrinol 2004; 2: 27–32
   Google Scholar
• Rein M S, Barbieri R L, Friedman A J. A critical role in the pathogenesis of uterine myomas. Am J Obstet Gynecol 1995; 172: 14–18
   PubMed Web of Science ®Google Scholar
• Buttram V C, Jr, Reiter R C. Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril 1981; 36: 433–445
   PubMed Web of Science ®Google Scholar
• Flake G P, Andersen J, Dixon D. Etiology and pathogenesis of uterine leiomyomas: a review. Environ Health Perspect 2003; 111: 1037–1054
   PubMed Web of Science ®Google Scholar
• Maruo T, Ohara N, Wang J, Matsuo H. Sex steroidal regulation of uterine leiomyoma growth and apoptosis. Hum Reprod Update 2004; 10: 207–220
   PubMed Web of Science ®Google Scholar
• Cesen-Cummings K, Houston K D, Copland J A, Moorman V J, Walker C L, Davis B J. Uterine leiomyomas express myometrial contractile-associated proteins involved in pregnancy-related hormone signaling. J Soc Gynecol Invest 2003; 10: 11–20
   PubMedGoogle Scholar
• Jaluvka V, Strecker J R, Weitzel H K. Uterus myomatosus mit seniler Hämatometra bei einer 101-jährigen Patientin. Zentralbl Gynakol 2002; 124: 135–136
   PubMedGoogle Scholar
• Hsieh Y-Y, Chang C-C, Hsu C-W, Lin C-S. Gene transfections with p53 and p21 inhibit cell proliferation, collagen type I, leukemia inhibitory factor, and tumor necrosis factor-α expression in leiomyoma cells. Fertil Steril 2004; 81: 1665–1670
   PubMedGoogle Scholar
• Lee E-J, Kong G, Lee S-H, Rho S B, Park C-S, Kim B-G, Bae D-S, Kavanagh J J, Lee J-H. Profiling of differentially expressed genes in human uterine leiomyomas. Int J Gynecol Cancer 2005; 15: 1461–1464
   Google Scholar
• Takahashi T, Nagai N, Oda H, Ohama K, Kamada N, Miyagawa K. Evidence for RAD5ILI/HMGIC fusion in the pathogenesis of uterine leiomyoma. Genes Chromosomes Cancer 2001; 30: 196–201
   PubMedGoogle Scholar
• Walker C L, Stewart E A. Uterine fibroids: the elephant in the room. Science 2005; 308: 1589–1592
   PubMed Web of Science ®Google Scholar
• Lee K H, Khan-Dawood F S, Dawood M Y. Oxytocin receptor and its messenger ribonucleic acid in human leiomyoma and myometrium. Am J Obstet Gynecol 1998; 179: 620–627
   PubMed Web of Science ®Google Scholar
• Cassoni P, Sapino A, Negro F, Bussolati G. Oxytocin inhibits proliferation of human breast cancer cell lines. Virchows Arch 1994; 425: 467–472
   PubMed Web of Science ®Google Scholar
• Cassoni P, Fulcheri E, Carcangiu M L, Stella A, Deaglio S, Bussolati G. Oxytocin receptors in human adenocarcinomas of the endometrium: presence and biological significance. J Pathol 2000; 190: 470–477
   PubMedGoogle Scholar
• Cassoni P, Sapino A, Stella A, Fortunati N, Bussolati G. Presence and significance of oxytocin receptors in human neuroblastomas and glial tumors. Int J Cancer 1998; 77: 695–700
   PubMed Web of Science ®Google Scholar
• Novak J F, Judkins M B, Chernin M I, Cassoni P, Bussolati G, Nitche J A, Nishimoto S K. A plasmin-derived hexapeptide from the carboxyl end of osteocalcin counteracts oxytocin-mediated growth inhibition [corrected] of osteosarcoma cells. Cancer Res 2000; 60: 3470–3476
   PubMed Web of Science ®Google Scholar
• Cassoni P, Marrocco T, Deaglio S, Sapino A, Bussolati G. Biological relevance of oxytocin and oxytocin receptors in cancer cells and primary tumors. Ann Oncol 2001; 12(Suppl 2)S37–S39
   PubMedGoogle Scholar
• Thibonnier M, Conarty D M, Preston J A, Plesnicher C L, Dweik R A, Erzurum S C. Human vascular endothelial cells express oxytocin receptors. Endocrinology 1999; 140: 1301–1309
   PubMed Web of Science ®Google Scholar
• Popovic A, Plecas B, Milicevic Z, Hristic M, Jovovic D. Stereologic analysis of ventral prostate of oxytocin-treated rats. Arch Androl 1990; 24: 247–253
   PubMed Web of Science ®Google Scholar
• Riley M, Baker P N, Tribe R M, Taggart M J. Expression of scaffolding, signaling and contractile-filament proteins in human myometria: effects of pregnancy and labor. J Cell Mol Med 2005; 9: 122–134
   PubMedGoogle Scholar
• Guzzi F, Zanchetta D, Cassoni P, Guzzi V, Francolini M, Parenti M, Chini B. Localization of the human oxytocin receptor in caveolin-1 enriched domains turns the receptor-mediated inhibition of cell growth into a proliferative response. Oncogene 2002; 21: 1658–1667
   PubMed Web of Science ®Google Scholar
• Palazzo J P, Mercer W E, Kovatich A J, McHugh M. Immunohistochemical localization of p21 (WAF1/CIP1) in normal, hyperplastic, and neoplastic uterine tissues. Hum Pathol 1997; 28: 60–66
   PubMedGoogle Scholar
• Herbert Z, Weigel S, Sendemir E, Marshall A, Caldwell J D, Petrusz P, Peuckert C, Jirikowski G F. Androgen-binding protein is co-expressed with oxytocin in the male reproductive tract. Anat Histol Embryol 2005; 34: 286–293
   PubMed Web of Science ®Google Scholar
• Schock H W, Herbert Z, Sigusch H, Figulla H R, Jirikowski G F, Lotze U. Expression of androgen-binding protein (ABP) in human cardiac myocytes. Horm Metab Res 2006; 38: 225–229
   PubMed Web of Science ®Google Scholar
• Herbert Z, Botticher G, Aschoff A, Sendemir E, Zermann D H, Arnold R, Mall G, Jinkowski G F. Changing Caveolin-1 and oxytocin receptor distribution in the aging human prostate. Anat Hist Embryol 2007; 36: 1–5
   Google Scholar
• Herbert Z, Jirikowski G F, Petrusz P, Englöf I, Caldwell J D. Distribution of androgen binding protein in the rat hypothalama-hypophyseal system, co-localization with oxytocin. Brain Res 2003; 992: 151–158
   PubMed Web of Science ®Google Scholar
• Jirikowski G F, Ramalho Ortigao F J, Lindl T, Seliger H. Immunocytochemistry of 5-bromo-2′-deoxyuridine labeled oligonucleotide probes. A novel technique for in situ hybridization. Histochemistry 1989; 91: 51–53
   PubMedGoogle Scholar
• Reventos J, Hammond G L, Crozat A, Brooks D E, Gunsalus G L, Bardin C W, Musto N A. Hormonal regulation of rat androgen-binding protein (ABP) messenger ribonucleic acid and homology of human testosterone–estradiol-binding globulin and ABP complementary deoxyribonucleic acids. Mol Endocrinol 1988; 2: 125–132
   PubMedGoogle Scholar
• Herbert Z, Pollak E, Molnar L, Caldwell J D, Jirikowski G F. Co-transport of sex hormone-binding globulin/SHBG with oxytocin in transport vesicles of the hypothalamo–hypophyseal system. Horm Metab Res 2006; 38: 291–293
   PubMed Web of Science ®Google Scholar
• Tsuchida T, Okazawa H, Mori T, Kobayashi M, Yoshida Y, Fujibayashi Y, Itoh H. In vivo imaging of estrogen receptor concentration in the endometrium and myometrium using FES PET – influence of menstrual cycle and endogenous estrogen level. Nucl Med Biol 2007; 34: 205–210
   PubMedGoogle Scholar
• Xing D, Feng W, Miller A P, Weathington N M, Chen Y F, Novak L, Blalock J E, Oparil S. Estrogen modulates TNF-α-induced inflammatory responses in rat aortic smooth muscle cells through estrogen receptor-β activation. Am J Physiol Heart Circ Physiol Jan 19, 2007, [Epub ahead of print]
   Google Scholar
• Misao R, Nakanishi Y, Fujimoto J, Tamaya T. Expression of sex hormone-binding globulin mRNA in uterine leiomyoma, myometrium and endometrium of human subjects. Gynecol Endocrinol 1995; 9: 317–323
   PubMed Web of Science ®Google Scholar
• Misao R, Nakanishi Y, Fujimoto J, Tamaya T. Expression of sex hormone-binding globulin exon VII splicing variant mRNA in human uterine myometrium and leiomyoma. J Steroid Biochem Mol Biol 1997; 63: 269–274
   PubMedGoogle Scholar
• Caldwell J D, Suleman F, Chou S H, Shapiro R A, Herbert Z, Jirikowski G F. Emerging roles of steroid-binding globulins. Horm Metab Res 2006; 38: 206–218
   PubMed Web of Science ®Google Scholar
• Ivell R, Fuchs A-R, Bathgate R, Tillmann G, Kimura T. Regulation of the oxytocin receptor in bovine reproductive tract tissues and the role of steroids. Reprod Domest Anim 2000; 35: 134–141
   Google Scholar
• Hilpert J, Vorum H, Burmeister R, Spoelgen R, Grishkovskaya I, Misselwitz R, Nykjaer A, Willnow T E. Efficient eukaryotic expression system for authentic human sex hormone-binding globulin. Biochem J 2001; 360: 609–615
   PubMedGoogle Scholar
• Ochedalski T, Subburaju S, Wynn P C, Aguilera G. Interaction between oestrogen and oxytocin on hypothalamic–pituitary–adrenal axis activity. J Neuroendocrinol 2007; 19: 189–197
   PubMed Web of Science ®Google Scholar
• Siebel A L, Gehring H M, Parry L J. Steroid-independent regulation of uterine oxytocin receptors. J Neuroendocrinol 2004; 16: 398–402
   PubMedGoogle Scholar
• Cassoni P, Sapino A, Marrocco T, Chini B, Bussolati G. Oxytocin and oxytocin receptors in cancer cells and proliferation. J Neuroendocrinol 2004; 16: 362–364
   PubMed Web of Science ®Google Scholar
• Jirikowski G F, Celeda D, Jantz M, Prufer K, Lee J S. Sense- and antisense-targeting of oxytocinergic systems in the rat hypothalamus. Adv Exp Med Biol 1995; 395: 59–65
   PubMedGoogle Scholar